Delivery Order SPE2DB25D3017-SPE2DB25FVGWW
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,641.41 firm fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 150ML, a medication used in the treatment of various medical conditions. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,412.69 firm fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 150ML, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,853.49 firm fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a pharmaceutical product, with an ultimate completion date of October 18, 2024. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,359.98, is for the delivery of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a pharmaceutical product, with a completion date of December 13, 2023. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,850.42 Firm Fixed Price Delivery Order contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a specialty medication. The contract has an ultimate completion date of October 25, 2024. This appears to be a task order issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, with ID SPE2DB22D2007|SPE2DB25FH8LU, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,745.73 Firm Fixed Price Delivery Order contract covers the supply of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a pharmaceutical product, with a period of performance through January 24, 2025. The contract award is associated with a larger Indefinite Delivery Contract (IDC) held...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,182.78 firm fixed price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 29, 2024 and was awarded on November 27, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,150.76 Firm Fixed Price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a prescription medication. The contract has an ultimate completion date of September 20, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with the DLA Troop Support...
This federal contract award, valued at $1,960.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QUILLIVANT XR 25 MG/5 ML SUSP 150ML, a pharmaceutical product, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,523.87 firm fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML suspension in 120 mL bottles, with a performance period through August 2, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...